3 Top Dividend Stocks Analysts Are Bullish on Right Now With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38.
Johnson & Johnson Highlights Multiple Blood Cancer Trial Data At ASCO Presentation Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple myeloma patients.
5 Cheap Stocks to Buy in June These stocks are ready for a summer surge.
Top 3 Reasons Savvy Investors Are Buying Johnson & Johnson Stock While Others Panic Over Lawsuits For long-term investors looking for both stability and innovation in the healthcare space, JNJ is a rare combination of both.
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.
Why Is Teva Stock Trading Higher On Tuesday? Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design.
Why Dan Loeb Just Made Kenvue One Of His Top Holdings Activist investor Dan Loeb's Third Point LLC acquired a significant stake in consumer health company Kenvue Inc. in Q1 2025.
Johnson & Johnson (NYSE:JNJ) – A Reliable Dividend Stock Worth Considering Johnson & Johnson (
NYSE:JNJ ) offers a strong dividend yield, consistent growth, and solid profitability, making it a compelling choice for income investors.
3 Buy-and-Hold Stocks Long-Term Investors Can Love in Any Market For buy-and-hold investors looking for some quality names to navigate a turbulent market, here are three stocks to consider
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Again US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys. Detroit & beyond are benefiting from this trend.
Meet the Warren Buffett Investment That's Gained 5,502,284% and Looks Set to Soar Even Higher Warren Buffett has had a lot of successful investments, but one in particular has crushed the stock market time and again.
